Pass Through

Discussion in 'Organogenesis' started by anonymous, Jan 25, 2018 at 10:41 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    How is life without pass through reimbursement?
     

  2. anonymous

    anonymous Guest

    Crickets.
    Get ready to be micromanaged.
     
  3. anonymous

    anonymous Guest

    It’s all about small wounds now. This company just cannot decide what it wants to be.
     
  4. anonymous

    anonymous Guest

    how is the surgical side? anyone putting this in in the OR. Is there Reimbursement?

    I'm new to Amnion just curious.
     
  5. anonymous

    anonymous Guest

    Amnions are a joke and not the savior of this company. However getting pass through back for puraply am maybe.

    If I was an investor I would run from this place as it is poorly run and the turnover rate should be a tell tale sign how mismanaged this company is.

    Complacency kills a company. Zero innovation or new data touting your FDA approved products showing superior outcomes is lacking. Knee jerk reactions to the market place is sad. Get a clue OI. You are not what you think you are anymore.
     
  6. anonymous

    anonymous Guest

     
  7. anonymous

    anonymous Guest

    Please please show something at SWAC this week
     
  8. anonymous

    anonymous Guest

    please please show something at SWAC this week
     
  9. anonymous

    anonymous Guest

    We will show how our ego's will get in the way with each other.
     
  10. anonymous

    anonymous Guest

    I hear pass through is coming back in October for two years, thanks to Trump. Has anyone else heard anything?
     
  11. anonymous

    anonymous Guest

    Of course it’s coming back. I talked to Trump and he said it’s going to be the best pass through ever, and MiMedix is going to pay for it.